Prof. Dr. EBRU ARIOĞLU İNAN

Yayın Ağı

Makaleler 45

1. Empagliflozin Protects Against Oxidative Stress in the Diabetic Brain by Inducing H2S Formation

Ozbek E. N., YEŞİLYURT DİRİCAN Z. E., Makal M., ARIOĞLU İNAN E., ANACAK G. Y.

Pharmaceuticals , cilt.18, sa.9, 2025 (SCI-Expanded)

2. β3-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation

Michel M. C., ARIOĞLU İNAN E., Hennenberg M.

Neurourology and Urodynamics , cilt.44, sa.7, ss.1498-1502, 2025 (SCI-Expanded)

3. SGLT2 inhibitors: how do they affect the cardiac cells

Erdogan B. R., ARIOĞLU İNAN E.

MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.480, sa.3, ss.1359-1379, 2025 (SCI-Expanded)

4. Sitagliptin does not improve isoprenaline-induced cardiac contractility in streptozotocin-induced diabetic rats

Boztas C. U., Erdogan B. R., Muderrisoglu A. E., KAYKI MUTLU G., YEŞİLYURT DİRİCAN Z. E., Karaomerlioglu I., et al.

ISTANBUL JOURNAL OF PHARMACY , sa.3, ss.359-367, 2024 (ESCI)

5. Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes

ERDOĞAN B., Yesilyurt-Dirican Z. E., Karaomerlioglu I., Muderrisoglu A. E., SEVİM K., Michel M. C., et al.

International Journal of Molecular Sciences , cilt.25, sa.19, 2024 (SCI-Expanded)

6. Investigation of the Expression of CYP3A4 in Diabetic Rats in Xenobiotic Metabolism

GÜVEN N. M., Karaomerlioglu I., ARIOĞLU İNAN E., Can Eke B.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.21, sa.1, ss.81-86, 2024 (ESCI)

7. Cardiac adrenergic receptors and GRKs: mitochondrial modulation in the heart

KAYKI MUTLU G., ARIOĞLU İNAN E.

Current Opinion in Physiology , cilt.37, 2024 (ESCI)

8. A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy

Ashfaq A., Meineck M., Pautz A., ARIOĞLU İNAN E., Weinmann-Menke J., Michel M. C.

Pharmacology and Therapeutics , cilt.249, 2023 (SCI-Expanded)

9. STREPTOZOTOCIN-INDUCED DIABETES HAS NO MAJOR EFFECTS ON THE ROLE OF SPHINGOSINE KINASE AND SPHINGOSINE-1-PHOSPHATE IN RAT BLADDER

Michel M., Rakhmatova G., Bese O., Kucukyildiz K., ARIOĞLU İNAN E., Michel M.

NEUROUROLOGY AND URODYNAMICS , cilt.42, 2023 (SCI-Expanded)

10. A comparison of urinary bladder weight in male and female mice across five models of diabetes and obesity

Erdogan B. R., Michel M. B., Matthes J., Castañeda T. R., Christen U., ARIOĞLU İNAN E., et al.

Frontiers in Pharmacology , cilt.14, 2023 (SCI-Expanded, Scopus)

11. Sex Differences in Glucose Homeostasis

ARIOĞLU İNAN E., KAYKI MUTLU G.

SEX AND GENDER EFFECTS IN PHARMACOLOGY , ss.219-239, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Development of salting-out extraction methodology for the determination of piroxicam from polymeric based nanocarriers and biological samples

Tok K. C., Gümüştaş M., Şengel Türk C. T., Amasya G., Bayram B., Arıoğlu İnan E.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS , 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Established and emerging treatments for diabetes-associated lower urinary tract dysfunction

Erdogan B. R., Liu G., ARIOĞLU İNAN E., Michel M. C.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , cilt.395, sa.8, ss.887-906, 2022 (SCI-Expanded, Scopus)

14. Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement

Yesilyurt Z. E., Matthes J., Hintermann E., Castaneda T. R., Elvert R., Beltran-Ornelas J. H., et al.

FRONTIERS IN PHYSIOLOGY , cilt.13, 2022 (SCI-Expanded, Scopus)

15. Validation of Fenoterol to Study beta(2)-Adrenoceptor Function in the Rat Urinary Bladder

Erdogan B. R., Yesilyurt Z. E., Arioglu-Inan E., Michel M. C.

PHARMACOLOGY , cilt.107, sa.1-2, ss.116-121, 2022 (SCI-Expanded, Scopus)

16. Function and morphology of the urinary bladder after denervation

Michel M. C., ARIOĞLU İNAN E.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY , cilt.320, sa.6, 2021 (SCI-Expanded, Scopus)

17. Effects of sitagliptin on beta-adrenoceptor mediated relaxation in streptozotocin-diabetic rat aorta

Muderrisoglu A. E., Erdogan B. R., YEŞİLYURT Z. E., Boztas C. U., Karacomerlioglu I., ALTAN V. M., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.864-872, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Effects of insulin treatment on hepatic CYP1A1 and CYP2E1 activities and lipid peroxidation levels in streptozotocin-induced diabetic rats

Kuzgun G., Basaran R., ARIOĞLU İNAN E., Can Eke B.

JOURNAL OF DIABETES AND METABOLIC DISORDERS , cilt.19, sa.2, ss.1157-1164, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

19. Expression and Signaling of beta-Adrenoceptor Subtypes in the Diabetic Heart

Erdogan B. R., Michel M. C., ARIOĞLU İNAN E.

CELLS , cilt.9, sa.12, 2020 (SCI-Expanded, Scopus)

20. Cardiac and Vascular alpha(1)-Adrenoceptors in Congestive Heart Failure: A Systematic Review

KAYKI MUTLU G., Papazisi O., Palmen M., Danser A. H. J., Michel M. C., ARIOĞLU İNAN E.

CELLS , cilt.9, sa.11, 2020 (SCI-Expanded, Scopus)

21. Normalization of organ bath contraction data for tissue specimen size: does one approach fit all?

Erdogan B. R., Karaomerlioglu I., Yesilyurt Z. E., ÖZTÜRK ERBOĞA N., Muderrisoglu A. E., Michel M. C., et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , cilt.393, sa.2, ss.243-251, 2020 (SCI-Expanded, Scopus)

22. Upregulation of beta(3)-adrenoceptors-a general marker of and protective mechanism against hypoxia?

Dal Monte M., Evans B. A., ARIOĞLU İNAN E., Michel M. C.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , cilt.393, sa.2, ss.141-146, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Beta-3 adrenoceptors: A potential therapeutic target for heart disease

KAYKI MUTLU G., Karaomerlioglu I., ARIOĞLU İNAN E., Altan V. M.

EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.858, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Urinary Bladder Weight and Function in a Rat Model of Mild Hyperglycemia and Its Treatment With Dapagliflozin

Yesilyurt Z. E., Erdogan B. R., Karaomerlioglu I., Muderrisoglu A. E., Michel M. C., ARIOĞLU İNAN E.

FRONTIERS IN PHARMACOLOGY , cilt.10, 2019 (SCI-Expanded, Scopus)

25. Cardiac beta(3)-adrenoceptors-A role in human pathophysiology?

ARIOĞLU İNAN E., KAYKI MUTLU G., Michel M. C.

BRITISH JOURNAL OF PHARMACOLOGY , cilt.176, sa.14, ss.2482-2495, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. EPİGALLOKATEŞİN GALLAT (EGCG)’IN NORMAL VE YÜKSEK GLUKOZ ORTAMINDA İZOLE SIÇAN KARDİYOMYOSİTLERİ ÜZERİNDEKİ DİREKT ETKİLERİ

KAYKI MUTLU G., Yeşilyurt Z. E., ERDOĞAN B. R., KARAÖMERLİOĞLU İ., Müderrisoğlu A. E., ARIOĞLU İNAN E., et al.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.43, sa.1, 2019 (Scopus)

27. The effect of nitric oxide synthase on beta 3 adrenoceptor mediated relaxation in STZ diabetic rat heart

KAYKI MUTLU G., Karaömerlioğlu I., ARIOĞLU İNAN E.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.43, sa.1, ss.64-71, 2019 (Scopus) Sürdürülebilir Kalkınma

28. Direct effects of epigallocatechin gallate (EGCG) on isolated rat cardiomyocytes under normal and high glucose concentrations Epigallokateşin Gallat (EGCG)'in normal ve yüksek glukoz ortaminda izole siçan kardiyomyositleri üzerindeki direkt etkileri

KAYKI MUTLU G., Yeşilyurt Z. E., Erdoğan B. R., Karaömerlioğlu I., Müderrisoğlu A. E., ARIOĞLU İNAN E., et al.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.43, sa.1, ss.72-78, 2019 (Scopus) Sürdürülebilir Kalkınma

29. A systematic review of urinary bladder hypertrophy in experimental diabetes: Part 2. Comparison of animal models and functional consequences

Ellenbroek J. H., ARIOĞLU İNAN E., Michel M. C.

NEUROUROLOGY AND URODYNAMICS , cilt.37, sa.8, ss.2346-2360, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Aging related functional and structural changes in the heart and aorta: MitoTEMPO improves aged-cardiovascular performance

OLĞAR Y., DEĞİRMENCİ S., DURAK A., BİLLUR D., CAN B., KAYKI MUTLU G., et al.

Experimental Gerontology , cilt.110, ss.172-181, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Role of the beta(3)-adrenergic receptor subtype in catecholamine-induced myocardial remodeling

Mutlu G., ARIOĞLU İNAN E., Karaomerlioglu I., ALTAN V. M., YERSAL N., KORKUSUZ P., et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY , cilt.446, sa.1-2, ss.149-160, 2018 (SCI-Expanded, Scopus)

32. A systematic review of urinary bladder hypertrophy in experimental diabetes: Part I. Streptozotocin-induced rat models

ARIOĞLU İNAN E., Ellenbroek J. H., Michel M. C.

NEUROUROLOGY AND URODYNAMICS , cilt.37, sa.4, ss.1212-1219, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Effects of incretin mimetic drugs on diabetic cardiovascular functions

Boztas C. U., Inan E., ALTAN V. M.

Fabad Journal of Pharmaceutical Sciences , cilt.42, sa.2, ss.151-165, 2017 (Scopus) Sürdürülebilir Kalkınma

34. Acetylsalicylic acid protects erectile function in diabetic rats

Hafez G., Gonulalan U., KOŞAN T. M., Arioglu E., Ozturk B., Cetinkaya M., et al.

Andrologia , cilt.46, sa.9, ss.997-1003, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. The role of insulin-thyroid hormone interaction on beta-adrenoceptor-mediated cardiac responses

ARIOĞLU İNAN E., ÖZAKCA GÜNDÜZ I., KAYKI MUTLU G., SEPİCİ DİNÇEL A., Altan V. M.

EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.718, sa.1-3, ss.533-543, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. The effect of diabetes mellitus on α1-adrenergic receptor subtypes in the bladder of rats

Gonulalan U., KOŞAN T. M., Hafez G., Arioglu E., Akdemir O., Ozturk B., et al.

Urology , cilt.80, sa.4, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. The changes in β-adrenoceptor-mediated cardiac function in experimental hypothyroidism: The possible contribution of cardiac β3-adrenoceptors

Arioglu E., Guner S., ÖZAKCA GÜNDÜZ I., Altan V. M., ÖZÇELİKAY A. T.

Molecular and Cellular Biochemistry , cilt.335, sa.1-2, ss.59-66, 2010 (SCI-Expanded, Scopus)

38. Diyabetik Sıçan Kalbinde İskemi/Reperfüzyon Hasarına Karşı Artmış Tolerans Kalp Atım Hızından Bağımsızdır

ALTUNKAYNAK ÇAMCA H. Ö., ARIOĞLU İNAN E., ÖZAKCA GÜNDÜZ I., KAYKI MUTLU G., ÖZÇELİKAY A. T.

Ankara Üniversitesi Eczacılık Fakültesi Dergisi , cilt.38, sa.4, ss.305-315, 2009 (Scopus) Sürdürülebilir Kalkınma

39. Increased tolerance against ischemia reperfusion injury in diabetic rat heart is independent from heart rate

ALTUNKAYNAK H. Ö., ARIOĞLU İNAN E., ÖZAKCA I., KAYKI MUTLU G., ÖZÇELİKAY A. T.

Journal of Faculty of Pharmacy of Ankara University , cilt.38, sa.4, ss.305-315, 2009 (Hakemli Dergi) Sürdürülebilir Kalkınma

40. INCREASED TOLERANCE AGAINST ISCHEMIA/REPERFUSION INJURY in DIABETIC RAT HEART IS INDEPENDENT from HEART RATE DİYABETİK SIÇAN KALBİNDE İSKEMİ/ REPERFÜZYON HASARINA KARŞI ARTMIŞ TOLERANS KALP ATIM HIZINDAN BAǦIMSIZDIR

Altunkaynak H. Ö., Arioǧlu E., ÖZAKCA GÜNDÜZ I., Kayki G., ÖZÇELİKAY A. T.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.38, sa.4, ss.305-315, 2009 (Scopus)

41. Role of beta-3-adrenoceptor in catecholamine-induced relaxations in gastric fundus from control and diabetic rats

ÖZAKCA GÜNDÜZ I., Arioglu E., Guner S., Altan V. M., ÖZÇELİKAY A. T.

Pharmacology , cilt.80, sa.4, ss.227-238, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts

BEŞİKCİ A., Guner S., Arioglu E., ÖZAKCA GÜNDÜZ I., ÖZÇELİKAY A. T., Altan V. M.

Canadian Journal of Physiology and Pharmacology , cilt.85, sa.5, ss.527-535, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. The influence of diabetes on cardiac β-adrenoceptor subtypes

Altan V. M., Arioglu E., Guner S., ÖZÇELİKAY A. T.

Heart Failure Reviews , cilt.12, sa.1, ss.58-65, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage

Guner S., Arioglu E., Tay A., Tasdelen A., Aslamaci S., Bidasee K., et al.

Molecular and Cellular Biochemistry , cilt.263, sa.1, ss.143-150, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Decreased expression of beta(1)- and beta(2)-adrenoceptors in human diabetic atrial appendage

Dincer U. D., Guner S., Tay A., ARIOĞLU İNAN E., Tasdelen A., Aslamaci S., et al.

CARDIOVASCULAR DIABETOLOGY , cilt.2, 2003 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 30

1. Insulin is Not Driving Urinary Bladder Enlargement in Rodent Models of Diabetes

Michel M. C., Beltrans-Ornelas J. H., Silva-Velasco D. L., Castaneda T. R., Elvert R., Kannt A., et al.

Experimental Biology Meeting (EB), Pennsylvania, Amerika Birleşik Devletleri, 2 - 05 Nisan 2022, (Özet Bildiri)

2. Optimization of HPLC method for the determination of piroxicam from polymeric based nanocarriers and biological samples

Gümüştaş M., Tok K. C., Bayram B., Amasya G., Arıoğlu İnan E., Şengel Türk C. T.

31st International Symposium on Pharmaceutical and Biomedical Analysis, Kyoto, Japonya, 29 Ağustos - 01 Eylül 2021, (Özet Bildiri)

3. An overview of the relation between blood glucose level and bladder enlargement in various diabetes models

Yesilyurt Z. E., Matthes J., Castaneda T. R., Christen U., ARIOĞLU İNAN E., Michel M. C.

Meeting of the British-Pharmacological-Society, Edinburgh, Saint Helena, 15 - 17 Aralık 2019, cilt.177, ss.2649-2650, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Does sacubitril/valsartan have an impact on cardiac function through beta-ARs in high-fat diet plus low-dose streptozotocin diabetes model?

Erdogan B. R., Yesilyurt Z. E., Karaomerlioglu I., Muderrisoglu A. E., SEVİM K., ARIOĞLU İNAN E.

Meeting of the British-Pharmacological-Society, Edinburgh, Saint Helena, 15 - 17 Aralık 2019, cilt.177, ss.2604-2605, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Bladder Enlargement Correlates with Plasma Insulin, Not Glucose Levels in Fructose-Fed Rats

Michel M., Beltran-Ornelas J., Silva-Velasco D., Yesilyurt Z., ARIOĞLU İNAN E., Centurion D.

Annual Meeting on Experimental Biology, California, Amerika Birleşik Devletleri, 4 - 07 Nisan 2020, cilt.34, (Özet Bildiri)

6. Changes in β-adrenoceptor mediated responses and protein expression in dapagliflozin treated HFD and low dose STZ diabetic rat heart

KARAÖMERLİOĞLU İ., Yeşilyurt Z. E., ERDOĞAN B. R., KAYKI MUTLU G., Müderrisoğlu A. E., ALTAN V. M., et al.

CVOT Summit 2019, Munich, Almanya, 24 - 25 Ekim 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

7. The effects of leptin on cardiac function in streptozotocin diabetic rats

ARIOĞLU İNAN E., KAYKI MUTLU G., ERDOĞAN B. R., Müderrisoğlu A. E., KARAÖMERLİOĞLU İ., Yeşilyurt Z. E., et al.

Pharmacology 2017, Londrina, Brezilya, 11 - 13 Aralık 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

8. Regulation of Na-K pump by β3-adrenergic receptors in aortas from noradrenaline-treated rats

KAYKI MUTLU G., Müderrisoğlu A. E., KARAÖMERLİOĞLU İ., ERDOĞAN B. R., ALTAN V. M., ARIOĞLU İNAN E.

Pharmacology 2017, Londrina, Brezilya, 11 - 13 Aralık 2017, (Özet Bildiri)

9. The effect of sitagliptin on beta-adrenoceptor-mediated cardiac responses in streptozotocin induced diabetic rats

UYAR BOZTAŞ C., ARIOĞLU İNAN E., MÜDERRİSOĞLU A. E., KAYKI MUTLU G., ERDOĞAN B. R., YEŞİLYURT Z. E., et al.

3rd CVOT (cardiovascular Outcome Trial) Summit Of The D CVD Study Group, Munich, Almanya, 26 - 27 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

10. The Effect Of Dapagliflozin Treatment On Beta Adrenoceptor-mediated Responses In High Fat Fed Diabetic Rat Heart

KARAÖMERLİOĞLU İ., KAYKI MUTLU G., ÖZTÜRK N., ERDOĞAN B. R., MÜDERRİSOĞLU A. E., YEŞİLYURT Z. E., et al.

3rd CVOT (cardiovascular Outcome Trial) Summit Of The D CVD Study Group, Munich, Almanya, 26 - 27 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

11. Effects of insulin treatment on hepatic CYP1A1 and CYP2E1 activities and lipid peroxidation levels in streptozotocin-induced diabetic rats

Eke B. C., Kuzgun G., Basaran R., ARIOĞLU İNAN E.

53rd Congress of the European-Societies-of-Toxicology (EUROTOX), Bratislava, Slovakya, 10 - 13 Eylül 2017, cilt.280, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Altered Heart Function In HighSucrose-fed Overweight Rats: In Vivo And In Vitro Investigations

ARIOĞLU İNAN E., Toy Durak A., Olgar Y., Tuncay E., KAYKI MUTLU G., KARAÖMERLİOĞLU İ., et al.

DCVD Annual Meeting, Milan, İtalya, 22 - 24 Haziran 2017, (Özet Bildiri)

13. Altered heart function in high sucrose fed overweight rats: ın vivo and in vitro investigations

ARIOĞLU İNAN E., toy durak a., olgar y., tuncay e., KAYKI MUTLU G., KARAÖMERLİOĞLU İ., et al.

DCVD Annual Meeting, 22 Haziran - 24 Temmuz 2017, (Özet Bildiri)

14. The role of CYP1A1 and CYP2E1 Enzyme Activities and Lipid peroxidation levels in diabetic rats

kuzgun g., başaran R., ARIOĞLU İNAN E., EKE B.

2nd International Conference on Enzymology and Molecular Biology, 20 - 21 Mart 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

15. The Role of CYP1A1 and CYP2E1 Enzyme Activities and Lipid Peroxidation Levels in Diabetics Rats

KUZGUN G., BAŞARAN R., ARIOĞLU İNAN E., EKE B.

2nd International Conference on Enzymology and Molecular Biology, 20 - 21 Mart 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

16. The effect of leptin treatment on in vivo cardiac parameters of streptozotocin induced diabetic rats

ARIOĞLU İNAN E., ERDOĞAN B. R., Müderrisoğlu E., KARAÖMERLİOĞLU İ., KAYKI MUTLU G., BEŞİKCİ A., et al.

9th Annual Meeting of the Diabetes and Cardiovascular Disease, 30 Haziran - 02 Temmuz 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

17. The Effect of Beta 3 ARs on Na K ATPase in Cardiac Hypertrophy

KAYKI MUTLU G., ARIOĞLU İNAN E., KARAÖMERLİOĞLU İ., ALTAN V. M.

7th European Congress of Pharmacology, 26 - 30 Haziran 2016, (Özet Bildiri)

18. The effect of thyroid hormone insulin interaction on diabetic rat aorta.

ARIOĞLU İNAN E., ÖZAKCA I., KAYKI MUTLU G., KARAÖMERLİOĞLU İ., ALTAN V. M.

ISOPS-11, 9 - 12 Haziran 2015, (Özet Bildiri) Sürdürülebilir Kalkınma

19. Beta 3 Adrenoceptor Mediated Responses In Diabetic Rat Thoracic Aorta

ARIOĞLU İNAN E., KAYKI MUTLU G., KARAÖMERLİOĞLU İ., ALTAN V. M.

7th Annual Meeting of the Diabetes and Cardiovascular Disease, Milan, İtalya, 6 - 08 Kasım 2014, (Özet Bildiri) Sürdürülebilir Kalkınma

20. The possible contribution of thyroid hormones to insulin effect on beta adrenoceptor mediated cardiac responses in diabetic rats

ARIOĞLU İNAN E., ÖZAKCA I., KAYKI MUTLU G., SEPİCİ DİNÇEL A., ALTAN V. M.

D&CVD 2012, 15 - 17 Kasım 2012 Sürdürülebilir Kalkınma

21. Nebivolol but not metoprolol prevents functional morphologic and molecular abnormalities induced by isoprenaline in rat heart

ÖZÇELİKAY A. T., ÖZAKCA I., ARIOĞLU İNAN E., ALTAN V. M.

6th European Congress of Pharmacology, EPHAR 2012, 17 - 20 Temmuz 2012, (Özet Bildiri)

22. Functional consequences of diabetes induced changes on the expression of cardiac beta-adrenoceptors in rats.

GÜNER Ş., ARIOĞLU İNAN E., ÖZAKCA I., ALTAN V. M.

4th Annual Meeting DCVD EASD Study Group Meeting, 27 - 29 Ekim 2011, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Increased tolerance by diabetes against ischemia reperfusion injury in rat heart is independent from heart rate

ALTUNKAYNAK H. Ö., ARIOĞLU İNAN E., ÖZAKCA I., KAYKI MUTLU G., ÖZÇELİKAY A. T.

International Symposium on New Approaches in Cardiovascular Disorders, NACD2011, 4 - 08 Mayıs 2011, (Özet Bildiri) Sürdürülebilir Kalkınma

24. The effects of diabetes on beta 3 adrenoceptor mediated cardiac responses

KAYKI MUTLU G., ARIOĞLU İNAN E., ÖZAKCA I., ÖZÇELİKAY A. T., ALTAN V. M.

14th Annual Meeting Of The European Council For Cardiovascular Research, Nice, Fransa, 9 - 11 Ekim 2009, cilt.54, ss.1180, (Özet Bildiri) Sürdürülebilir Kalkınma